Doctors Note Logo

Published on: 5/22/2026

How to Find a Clinical Trial for Treatment-Resistant Chronic Hives: Next Steps

Finding a clinical trial for treatment-resistant chronic hives involves confirming your diagnosis and treatment history, consulting a specialist, and searching reputable registries for studies that suit your needs.

You’ll then review eligibility criteria, contact trial sites with key questions, weigh risks and benefits, prepare for screening visits, and plan for post-trial care. See below for all the important details and considerations that could impact your next steps.

answer background

Explanation

How to Find a Clinical Trial for Treatment-Resistant Chronic Hives: Next Steps

Living with chronic hives (also known as chronic urticaria) that don't respond to standard treatments can be frustrating. Clinical trials offer access to cutting-edge therapies and expert care teams. This guide walks you through the process of finding a trial that may suit your needs, using reliable resources and practical steps.


1. Confirm Your Diagnosis and Treatment History

Before seeking a clinical trial, make sure your chronic hives diagnosis and treatment history are up to date:

  • Visit a board-certified allergist or dermatologist.
  • Review all medications you've tried, including:
    • Second-generation antihistamines (e.g., cetirizine, loratadine)
    • Up-dosing of antihistamines
    • H2 blockers or leukotriene receptor antagonists
    • Injectable biologics (e.g., omalizumab)
  • Ask your doctor to document:
    • Duration and severity of your hives
    • Lab tests or biopsy results (if performed)
    • Any suspected triggers or patterns

Accurate records help you and trial coordinators determine eligibility and safety.


2. Talk to Your Doctor or Specialist

Clinical trials often require a referral or letter of medical necessity:

  • Discuss your interest in finding a clinical trial for treatment-resistant chronic hives.
  • Ask if your doctor is aware of ongoing or upcoming trials.
  • Request contact information for research coordinators or academic centers specializing in urticaria.

Your doctor's support can smooth the enrollment process and ensure continuity of care.


3. Search Reputable Clinical Trial Registries

Several trusted registries list active clinical trials. While you won't link directly to them here, you can access these by entering their names in your web browser:

  • ClinicalTrials.gov (U.S. National Library of Medicine)
  • CenterWatch
  • World Health Organization International Clinical Trials Registry Platform (ICTRP)

When searching, use keywords such as:

  • "Chronic urticaria"
  • "Chronic spontaneous urticaria"
  • "Treatment-resistant chronic hives"
  • "Urticaria biologic therapy trial"

Pay attention to:

  • Location (country, city)
  • Phase (II, III, etc.)
  • Trial status (recruiting, not yet recruiting)
  • Sponsor (academic institution, pharmaceutical company)

4. Review Eligibility Criteria

Each trial has specific requirements. Common criteria include:

  • Age range (e.g., 18–65 years)
  • Confirmed diagnosis of chronic spontaneous urticaria for at least 6 months
  • Previous treatment failures or resistance
  • Laboratory values within safe limits (e.g., liver and kidney function)
  • No recent participation in another investigational study

Create a checklist to compare your medical history against each trial's criteria. If you're uncertain, reach out to the trial coordinator with your questions.


5. Contact Trial Sites and Ask Key Questions

Once you've identified a promising trial, reach out by phone or email. Good questions to ask include:

  • What is the main goal of this study?
  • How many clinic visits and procedures are required?
  • Are there any costs I must cover (e.g., travel, tests)?
  • Will I receive compensation for participation?
  • What are the potential risks and side effects?
  • What happens after the trial ends—will I have access to the study drug if it works?

Taking notes during these conversations helps you compare options and make an informed choice.


6. Weigh Risks and Benefits

Enrolling in a clinical trial involves potential benefits and drawbacks:

Potential Benefits

  • Access to new treatments not yet available to the public
  • Close monitoring by a research team
  • Contribution to medical knowledge that may help others

Potential Risks

  • Unknown side effects or limited safety data
  • Time commitment for appointments and tests
  • Possible need to stop current medications

Discuss these factors with your family, support network, and healthcare providers.


7. Prepare for the Screening Visit

If you decide to proceed, the trial site will schedule a screening visit to confirm your eligibility. To prepare:

  • Gather medical records, lab results, and medication lists.
  • Bring photo ID and insurance information (if required).
  • Write down questions or concerns about the trial protocol.
  • Plan for travel time, parking, and potential time off work.

Screening visits may last several hours and include blood draws, physical exams, and questionnaires.


8. Stay Organized and Informed

Managing trial participation alongside daily life can be challenging. Use these tips:

  • Create a dedicated folder (digital or physical) for trial documents.
  • Keep a calendar of appointments, medication schedules, and follow-up visits.
  • Set reminders on your phone for symptom tracking or medication intake.
  • Join a patient support group (online or local) for chronic urticaria.

Consistent communication with the research team ensures you stay on track and report any concerns promptly.


9. Monitor Your Symptoms

Throughout the trial, you'll likely track your hives and related symptoms. Regular monitoring helps both you and the research team:

  • Note the number, size, and duration of hives each day.
  • Record itching intensity on a simple 0–10 scale.
  • Log any new medications or changes in diet, stress, or environment.

Before approaching a trial, you can use a free AI-powered Chronic Urticaria symptom checker to better understand your condition, identify patterns in your symptoms, and prepare informed questions to share with your care team and trial coordinators.


10. Plan for Life After the Trial

Clinical trials have defined durations. Before you enroll, ask about:

  • Post-trial access to effective treatments
  • Long-term follow-up visits
  • Support for managing side effects after the study
  • How and when you'll learn the overall study results

Knowing what happens next helps you maintain continuity of care and make future treatment decisions.


11. Additional Resources and Patient Advocacy

Patient advocacy groups can offer support, education, and updates on new trials:

  • Asthma and Allergy Foundation of America (AAFA)
  • European Academy of Allergy and Clinical Immunology (EAACI)
  • Local urticaria support networks or online forums

These organizations often provide newsletters, webinars, and community connections.


Final Thoughts

Finding and enrolling in a clinical trial takes time, research, and collaboration with your healthcare team. Trials can offer hope when standard treatments fail, but they also require careful consideration of risks, benefits, and practical details.

Remember to:

  • Keep your medical records current.
  • Maintain open communication with your doctor and trial coordinators.
  • Stay organized with symptom logs and appointment schedules.
  • Discuss any life-threatening or serious concerns with a qualified healthcare professional immediately.
  • Speak to a doctor about any potential risks or side effects before making decisions.

Your proactive steps today could lead to better treatments—and a brighter tomorrow—for yourself and others living with treatment-resistant chronic hives.

(References)

  • * Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Aygören-Pürsün E, Bindslev-Jensen C, Brockow K, Caballero T, Camgoz B, Cardona V, D'Amato G, Dawson L, Fomina D, Ghazanfar MN, Giménez-Arnau AM, Grattan C, Hide M, Hötzenecker W, Ishii N, Jochmann A, Kambe N, Kaplan AP, Kocatürk E, Kolkhir P, Kothari A, K Sterling K, Magerl M, Makris M, Maurer M, Mustafa S, Nakazawa K, Niedoszytko M, Ohsawa I, Ortac C, Paulino M, Peter J, Pfaar O, Radonjic-Häkli E, Reich A, Reichrath J, Rodríguez-González M, Ruëff F, Saini SS, Salek G, Sánchez-Borges M, Schäfer G, Schmid-Grendelmeier P, Sheikh A, Sindrilaru A, Stelzle J, Thomsen SF, Vadas P, Vestergaard C, Vlahopoulos S, Vonakis I, Wagner N, Wemeau AC, Wedi B, Xepapadaki P, Zampeli V, Zuberbier T. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022 Mar;77(3):825-866. doi: 10.1111/all.15090. Epub 2021 Nov 16. PMID: 34791689.

  • * Maurya A, Arora T, Singh BP, Rawat S, Kumar V, Singh P, Vasanthapuram R, Saini SS, Sarin S. Management of Chronic Spontaneous Urticaria Refractory to Standard Therapies: Beyond Antihistamines. J Allergy Clin Immunol Pract. 2022 Jul;10(7):1748-1756. doi: 10.1016/j.jacip.2022.04.030. Epub 2022 May 3. PMID: 35523554.

  • * Kolkhir P, Altrichter S, Hawro T, Skov PS, Zuberbier T, Maurer M. Emerging Therapeutic Options for Chronic Spontaneous Urticaria. Drugs. 2022 May;82(7):737-759. doi: 10.1007/s40265-022-01708-3. Epub 2022 Apr 20. PMID: 35441315.

  • * Saini SS. Chronic Spontaneous Urticaria: Pathogenesis, Diagnosis, and Treatment. Allergy Asthma Proc. 2022 Mar 22;43(2):107-113. doi: 10.2500/aap.2022.43.210086. PMID: 35308873.

  • * Weller K, Zuberbier T. Unmet needs in chronic spontaneous urticaria: Future directions. Clin Rev Allergy Immunol. 2019 Jun;56(3):362-371. doi: 10.1007/s12016-018-8725-3. PMID: 30467773.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.